medrxiv.org — September 2026 traffic, keywords & AI visibility

Search engines send medrxiv.org an estimated 57,700 visits a month. Effectively all of it is organic — about 57,700 visits from unpaid results. Spread across 16,500 ranking keywords, that averages roughly 3.5 organic visits per keyword.

medrxiv.org scores 90 out of 100 on our AI visibility scale, grade A+. It takes full marks for LLMS.txt and Structured data. The biggest gap is Crawlability, at 5 of 10 points (robots ✓ · sitemap ✗), worth 5 points if closed. It also loses points on Company profile (22/25) and SEO health (18/20).

The llms.txt on medrxiv.org runs to 149 lines (7,488 characters) across 12 sections, last generated in May 2026. It introduces the site as "medRxiv". It tells AI engines the business works in Medical Research, Healthcare, Public Health and Clinical Trials. It describes 4 products, with prices such as Preprint Submission at Free, Document Search at Free and Subject Categories at Free. Services it lists include Manuscript Screening, DOI Assignment, Version Updates and Data Sharing Guidance. The audience it names is Researchers, clinicians, health policymakers, aged 25-65 (Global). Technologies it mentions include HTTPS and Robots.txt. The keywords it claims start with "medical research", "healthcare", "clinical trials" and "public health".

# medRxiv

## About
medRxiv operates as a dynamic preprint server tailored for the health sciences, enabling researchers to upload manuscripts swiftly without the delays of peer review. It spans clinical research, epidemiology, public health, and policy analyses, with a spotlight on urgent topics like pandemics. The platform's non-profit roots ensure free access for all, promoting equity in scientific exchange. Submitters range from academic labs to industry teams, while readers include doctors tracking trial data and officials shaping responses. Screening catches major flaws upfront, yet preserves preprint speed. COVID-19 catapulted its prominence, hosting pivotal early studies on vaccines and variants. Features like DOIs and version tracking aid proper citation. Community guidelines stress responsible sharing, including data availability. Search filters by subject or recency keep users ahead of trends. Exports to formats like PDF or XML simplify use. Global adoption reflects its borderless appeal. Partnerships enhance interoperability with journals. Retraction policies maintain integrity. It's reshaping how health knowledge flows, from lab to action. Annual stats reveal explosive growth in submissions. Mobile-friendly design, despite tweaks needed, serves on-the-go pros. No paywalls mean broader impact. Future plans eye AI aids for discovery. In essence, medRxiv fuels faster,

Google lists medrxiv.org for about 16,500 keywords, which together bring an estimated 57,700 organic visits a month.

The latest technical audit of medrxiv.org scored 94 out of 100 overall. Accessibility is its weakest area at 87, while performance scores highest at 96. The audit makes 12 recommendations in all, and 4 of the 4 listed first are rated high priority or critical.

medRxiv's company profile names https://www.ncbi.nlm.nih.gov, https://www.researchgate.net, https://www.sciencedirect.com and https://www.jamanetwork.com as competitors. Its own llms.txt adds https://www.bmj.com and https://www.springer.com. Outside its market, the domains ranked closest to it in our worldwide ranking are claro.com.br, adme.media, controlup.com and dmitriy-mevedev-tor.top.

https://www.ncbi.nlm.nih.gov

https://www.researchgate.net

https://www.sciencedirect.com

https://www.jamanetwork.com

https://www.bmj.com

https://www.springer.com